P

Inventor

KOLLURI RAO

US30 patents
⚠️ This page may combine multiple inventors who share the name “KOLLURI RAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIGEL PHARMACEUTICALS INC

25 patents
US11407736B2Aug 9, 2022

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC4 citations84
US9566278B2Feb 14, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC6 citations84
US9321763B2Apr 26, 2016

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC6 citations84
US8377924B2Feb 19, 2013

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC9 citations82
US11110082B2Sep 7, 2021

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US10434096B2Oct 8, 2019

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US10130623B2Nov 20, 2018

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC2 citations73
US9913843B2Mar 13, 2018

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US9732070B2Aug 15, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US9682976B2Jun 20, 2017

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC3 citations73
US9181222B2Nov 10, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US9169249B2Oct 27, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC4 citations73
US9149475B2Oct 6, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC5 citations71
US12297202B2May 13, 2025

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11672791B2Jun 13, 2023

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US11667643B2Jun 6, 2023

RIP1K inhibitors

RIGEL PHARMACEUTICALS INC0 citations62
US7776847B2Aug 17, 2010

Benzisothiazoles useful for treating or preventing HCV infection

RIGEL PHARMACEUTICALS INC3 citations59
US11578078B2Feb 14, 2023

Heterocyclic RIP1 inhibitory compounds

RIGEL PHARMACEUTICALS INC0 citations52
US11564930B2Jan 31, 2023

RIP1 inhibitory compounds and methods for making and using the same

RIGEL PHARMACEUTICALS INC0 citations52
US10792282B2Oct 6, 2020

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US10005777B2Jun 26, 2018

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US9062068B2Jun 23, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations52
US9453028B2Sep 27, 2016

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations51
US9095593B2Aug 4, 2015

Protein kinase C inhibitors and uses thereof

RIGEL PHARMACEUTICALS INC0 citations51
US10851093B2Dec 1, 2020

Tyrosine kinase inhibitors

RIGEL PHARMACEUTICALS INC0 citations42

NURA BIO INC

2 patents

HOLLAND SACHA

1 patent

SINGH RAJINDER

1 patent

ZHAO HAORAN

1 patent